The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSophos Group Regulatory News (SOPH)

  • There is currently no data for SOPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Sophos Group plc

5 Dec 2019 08:07

RNS Number : 7955V
Sophos Group Plc
05 December 2019
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

AMENDMENT - CHANGE TO SECTION 3C

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Sophos Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Sophos Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

24 October 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

 

(a) Interests held by the directors of Sophos Group plc and their close relatives and related trusts

 

Name

Number of ordinary shares

% of total issued share capital (excluding share options)

Sandra Bergeron

214,974

0.044%

Nick Bray

281,282

0.058%

Nick Bray / close relative

22,000

0.005%

Peter Gyenes

286,631

0.059%

Kris Hagerman

2,802,125

0.574%

Rick Medlock / close relative

415

0.00008%

Vin Murria

50,000

0.010%

Paul Walker

190,694

0.039%

 

(b) Interests held as options or awards under the share plans of Sophos Group plc by the directors of Sophos Group plc and their close relatives and related trusts who are not exempt principal traders for the purposes of Rule 8 of the Code.

 

Name

Share Plan

Number of ordinary shares under option/ award

Vesting date / period

Exercise price (per share)

Nick Bray

Long Term Incentive Plan (PSU)

299,988

14 June 2019

Nil

200,893

16 June 2020

Nil

148,351

14 June 2021

Nil

Long Term Incentive Plan (RSU)

7,023

7 August 2016 to 7 August 2019

Nil

210,675

7 August 2016 to 7 August 2020

Nil

46,640

14 June 2017 to 14 June 2020

Nil

32,498

16 June 2018 to 16 June 2021

Nil

37,089

14 June 2019 to 14 June 2022

Nil

Save As You Earn

11,111

8 August 2019

£1.62 GBP

Kris Hagerman

Pre-IPO Options

3,593,067

1 July 2015

$0.598 USD

315,285

1 August 2013 to 1 August 2017

$0.598 USD

Long Term Incentive Plan (PSU)

491,573

7 August 2018

Nil

665,714

14 June 2019

Nil

492,763

16 June 2020

Nil

350,291

14 June 2021

Nil

Long Term Incentive Plan (RSU)

14,923

7 August 2016 to 7 August 2019

Nil

103,501

14 June 2017 to 14 June 2020

Nil

79,712

16 June 2018 to 16 June 2021

Nil

87,573

14 June 2019 to 14 June 2022

Nil

Employee Stock Purchase Plan

2,488

31 December 2019

US$4.27

 

(c) Interests and short positions held by connected advisers of Sophos Group plc

 

No interests, short positions or rights to subscribe are held by Sophos Group plc's connected advisers J.P. Morgan Cazenove, Lazard & Co., Ltd. or UBS AG London Branch, or the persons affiliated with them, who are not exempt principal traders for the purposes of the Rule 8 of the Code.

 

This disclosure amends and restates the statement in section 3.4 of Part VIII of the scheme circular published by Sophos Group plc on 8 November 2019.

 

(d) Interests, short positions and rights to subscribe held by other presumed concert parties of Sophos Group plc

 

Name

Number of ordinary shares

% of total issued share capital (excluding share options)

Dr. Peter Lammer

42,543,360

8.708%

Dr. Jan Hruska

37,085,228

7.591%

Dr. Jan Hruska / related trust

5,458,132

1.117%

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 December 2019

Contact name:

Paul Waters, Company Secretary

Telephone number:

+44 (0)1235 461 908

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEVELBBKLFBFBL
Date   Source Headline
2nd Mar 20203:20 pmRNSForm 8.3 - Sophos Group PLC
2nd Mar 20203:15 pmBUSFORM 8.3 - SOPHOS GROUP PLC
2nd Mar 202012:52 pmBUSFORM 8.3 - SOPHOS GROUP PLC
2nd Mar 202012:50 pmRNSForm 8.3 - Sophos Group plc
2nd Mar 202011:07 amRNSForm 8.5 (EPT/RI)
2nd Mar 202010:52 amRNSForm 8.5 (EPT/RI)Sophos Group plc
2nd Mar 202010:38 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
2nd Mar 20209:10 amRNSScheme of arrangement
2nd Mar 20207:30 amRNSSuspension-Sophos Group PLC
28th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
28th Feb 20203:15 pmBUSForm 8.3 - Sophos Group PLC
28th Feb 20203:03 pmBUSForm 8.3 - Sophos Group plc
28th Feb 20202:44 pmRNSForm 8.3 - Sophos Group Plc
28th Feb 20201:53 pmRNSHolding(s) in Company
28th Feb 20201:28 pmRNSForm 8.3 - Sophos Group Plc
28th Feb 202011:37 amRNSForm 8.5 (EPT/RI)
28th Feb 202011:06 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
28th Feb 202010:27 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
27th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
27th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
27th Feb 20202:38 pmBUSFORM 8.3 - SOPHOS GROUP PLC
27th Feb 20202:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
27th Feb 20202:22 pmBUSForm 8.3 - Sophos Group PLC
27th Feb 20202:04 pmRNSForm 8.3 - Sophos Group PLC
27th Feb 20201:07 pmRNSScheme Timetable Update
27th Feb 202011:55 amRNSForm 8.3 - Sophos Group Plc
27th Feb 202011:28 amRNSForm 8.5 (EPT/RI)
27th Feb 202011:23 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
27th Feb 202010:43 amRNSForm 8.5 (EPT/NON-RI)- Sophos Group plc
27th Feb 202010:40 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
27th Feb 20208:23 amRNSRule 2.9 Announcement
26th Feb 20206:15 pmRNSSophos Group
26th Feb 20204:41 pmRNSScheme Timetable Update
26th Feb 20204:29 pmRNSForm 8.3 - Sophos Group Plc
26th Feb 20203:30 pmRNSForm 8.3 - SOPH LN
26th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
26th Feb 20203:19 pmRNSForm 8.3 - Sophos Group PLC
26th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
26th Feb 20202:57 pmRNSForm 8 (DD) - Sophos Group Plc
26th Feb 20202:51 pmRNSDirector/PDMR Shareholding
26th Feb 20201:31 pmBUSFORM 8.3 - SOPHOS GROUP PLC
26th Feb 202011:26 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
26th Feb 202010:56 amRNSForm 8.5 (EPT/RI)
26th Feb 202010:34 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
25th Feb 20204:39 pmRNSForm 8.3 - Sophos Group plc
25th Feb 20203:43 pmRNSForm 8.5 (EPT/RI) - Amendment
25th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
25th Feb 20203:15 pmBUSFORM 8.3 - SOPHOS GROUP PLC
25th Feb 20203:00 pmBUSForm 8.3 - SOPHOS GROUP PLC
25th Feb 20202:29 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.